EcoR1 Capital as of Dec. 31, 2015
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 31 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fibrogen | 11.6 | $37M | 1.2M | 30.47 | |
| Five Prime Therapeutics | 9.4 | $30M | 719k | 41.50 | |
| Jazz Pharmaceuticals Plc cmn | 8.3 | $27M | 189k | 140.56 | |
| Retrophin | 7.4 | $24M | 1.2M | 19.29 | |
| Array Biopharma Inc note 3.000% 6/0 | 6.8 | $22M | 23k | 960.02 | |
| Kura Oncology (KURA) | 6.5 | $21M | 2.5M | 8.40 | |
| Assembly Biosciences | 5.0 | $16M | 2.1M | 7.51 | |
| Cytokinetics (CYTK) | 4.7 | $15M | 1.4M | 10.46 | |
| VALEANT PHARMACEUTICALS Inte call | 4.0 | $13M | 127k | 101.65 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 4.0 | $13M | 465k | 27.50 | |
| Epizyme | 3.5 | $11M | 699k | 16.02 | |
| Galapagos Nv- (GLPG) | 3.3 | $11M | 167k | 62.88 | |
| Kite Pharma | 3.2 | $10M | 166k | 61.62 | |
| Flex Pharma | 3.1 | $9.9M | 795k | 12.45 | |
| Ironwood Pharmaceuticals (IRWD) | 3.0 | $9.5M | 822k | 11.59 | |
| Nabriva Therapeutics | 2.5 | $7.9M | 839k | 9.46 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 2.4 | $7.8M | 791k | 9.83 | |
| Kindred Biosciences | 1.5 | $4.9M | 1.4M | 3.40 | |
| Retrophin | 1.5 | $4.7M | 244k | 19.29 | |
| Celladon | 1.3 | $4.2M | 2.8M | 1.47 | |
| Ovascience | 1.3 | $4.2M | 425k | 9.77 | |
| Genvec | 1.1 | $3.5M | 1.9M | 1.84 | |
| Calithera Biosciences | 1.0 | $3.2M | 416k | 7.66 | |
| Cytokinetics | 0.9 | $3.0M | 285k | 10.46 | |
| Zafgen | 0.7 | $2.3M | 369k | 6.29 | |
| Forward Pharma A/s | 0.6 | $1.9M | 100k | 19.00 | |
| Akari Therapeutics | 0.5 | $1.5M | 101k | 14.50 | |
| Gilead Sciences Inc option | 0.4 | $1.2M | 12k | 101.19 | |
| Nephrogenex | 0.3 | $941k | 588k | 1.60 | |
| Qlt | 0.1 | $266k | 100k | 2.66 | |
| Zafgen | 0.0 | $63k | 10k | 6.30 |
